MESO — MESOBLAST LTD

—
Nasdaq · Health Care · Biotechnology · CIK 1345099 ·
Last close
$11.91
Market Cap
$1.55B
52W High
$21.50
52W Low
$11.74
ADV30
271,903
Next earnings
2026-08-26

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 — — — — 773,079,000 47,390,000 204,674,000
Mar 2026 — — — — — — —
Dec 2025 — — — — 782,307,000 129,573,000 207,623,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,068,403,000
Inventory
$28,111,000
Receivables
$57,660,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$120,250,000
EBITDA
$-44,605,000
Free Cash Flow
$-51,976,248
Enterprise Value
$2,038,132,864
Total Cash
$102,914,000
Total Debt
$127,334,000
Shares Out
129,854,878
Trailing EPS
$-0.44
Book Value
$4.38
ROE
-9.9%
ROA
-4.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 120,250,000 -51,250,000 -57,500,000 773,079,000 204,674,000 568,405,000 —
Jun 2025 17,198,000 -62,443,000 -102,142,000 784,683,000 187,241,000 597,442,000 -49,954,000
Jun 2024 5,902,000 -56,224,000 -87,956,000 669,153,000 188,798,000 480,355,000 -48,458,000
Jun 2023 7,501,000 -69,289,000 -81,889,000 669,415,000 167,577,000 501,838,000 -63,269,000
Jun 2022 — — — — — — -65,782,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.46

Max Pain — expiry 2028-01-21

max pain strike: $8.00 · spot: $11.64 · call oi: 16,343 · put oi: 167
Expected Move to 2028-01-21: ±$8.12 (69.80%) — implied range $3.52 – $19.77 · ATM straddle on $12.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ALVO Alvotech $1.56B $4.37 —
VIR Vir Biotechnology, Inc. $1.58B $9.25 —
LYCA Lycia Therapeutics, Inc. $1.61B $30.92 —
MEOBF MESOBLAST LTD $1.48B $1.14 —
IMCR Immunocore Holdings plc $1.43B $27.81 —

News headlines (Yahoo Finance, 1h cache)

Mesoblast Showcased at ASX Premier Investor Day Event
2026-11-15 23:16 · Yahoo
Mesoblast Posts $115 Million in Revenue, Sets Sights on 2027 Back Pain Trial Readout
2026-11-12 09:12 · Yahoo
Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar
2026-11-05 00:11 · Yahoo
Our Pick Of The Best Australian Founder Led Stocks In November 2026
2026-11-18 21:11 · Yahoo
Pro Medicus And 2 Other Australian Founder Led Stocks
2026-11-17 20:12 · Yahoo
Top 3 Australian Owner Operator Stocks To Watch In November 2026
2026-11-16 19:15 · Yahoo
Top 3 Australian Founder Led Stocks To Watch In November 2026
2026-11-15 12:11 · Yahoo
3 Australian Growth Stocks To Own In November 2026
2026-11-13 23:14 · Yahoo
3 Australian Founder Led Stocks With Revenue Growth Up To 38%
2026-11-13 07:13 · Yahoo
3 Australian Healthcare Stocks With Earnings Growth Over 21%
2026-11-12 20:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.